Impaired anti-oxidant defense mechanism in central eales disease

Annals of Ophthalmology

Volumn 36, Issue 1, 2004, Pages 29-31

  Saxena, Sandeep ^a,b   Kumar, Dipak ^b   Khanna, Vinay K ^c   Srivastava, Prachi ^b   Seth, Prahlad K ^c  

^a G 19 River Bank Colony   (India)

^b UNIVERSITY OF LUCKNOW   (India)

^c CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; ENZYME; GLUTATHIONE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CASE CONTROL STUDY; CENTRAL EALES DISEASE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; EALES DISEASE; FEMALE; HUMAN; HUMAN CELL; MALE; MEMBRANE FLUIDITY; OXIDATIVE STRESS; THROMBOCYTE MEMBRANE;

EID: 3042723299     PISSN: 15304086     EISSN: None     Source Type: Journal    
DOI: 10.1385/AO:36:1:29     Document Type: Article

References (22)

1. Gieser SC, Murphy RP. Eales' disease. In: Ryan SJ, ed. Retina. Vol II. Medical Retina. St. Louis: CV Mosby; 1994:1503-7.
2. Kumar D, Saxena RC, Saxena S. Vitreous haemorrhage in Eales disease. Afro Asian J Ophthalmol. 1995;13:109-12.
3. Gieser SC, Murphy RP, Das TP. Eales' disease. In: Roy FH, ed. Master Techniques in Ophthalmology. Philadelphia; Williams and Wilkins: 1995:1063-8.
4. Saxena S, Kumar D, Singh VK, Rajasingh J. Immunological studies in Eales' disease. A review. Afro Asian J Ophthalmol. 1995;13: 19-22.
5. Muthukkaruppan VR, Rengarajan K, Chakkalath HR, Namperumalsamy P. Immunological status of patients of Eales' disease. Ind J Med Res. 1989;90:351-9.
6. Saxena S, Rajasingh J, Biswas S, Kumar D, Shinohara T, Singh VK. Cellular response to retinal S-antigen and interphotoreceptor retinoid binding protein fragments in Eales' disease patients. Pathobiology. 1999;67:37-44.
7. Fong ACO, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol. 1993;37:393-417.
8. Duke-Elder S, Dobree JH. Vasculitis. In: System of Ophthalmology, Vol. X. London: Henry Kimpton; 1967:218-36.
9. Anderson RE, Andrews LM. Biochemistry of photoreceptor membrane in vertebrates and invertebrates. In: Westfall J, ed. Visual Cells in Evolution. New York: Raven Press; 1982:1-22.
10. Saxena S, Kumar D, Srivastava P, Khanna VK, Seth PK. Low levels of platelet glutathione in Eales' disease. Med Sci Res. 1999;42: 125-6.
11. Saxena S, Khanna VK, Kumar D, Srivastava P, Seth PK. Enhanced oxidative stress in Eales disease. Ann Ophthalmol. 2001;33:40-42.
12. Srivastava S, Joshi CS, Sethi PPS, Agrawal AK, Srivastava SK, Seth PK. Altered platelet function in non-insulin dependent diabetes mellitus (NIDDM). Thrombosis Res. 1994;76:451-61.
13. Nishikimi M, Rao NA, Kunio Y. The occurrence of superoxide anion in reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Res Comm. 1972;46:849-53.
14. Aebi H. Catalase in vitro. Meth Enzymol. 1984;105:121-6.
15. Hasan M, Haider SS. Acetylhomocysteine thiolactone protects against some neurotoxic effects of thallium. Neurotoxicology. 1989;10:257-62.
16. Shattil SJ, Cooper RA. Membrane microviscosity and human platelet function. Biochemistry. 1976;15:4832-7.
17. Atmaca LS, Idil A, Gunduz K. Visualization of retinal vasculitis in Eales' disease. Ocular Immunol Inflamm. 1993;1:41-8.
18. Appiah A, Trempe CL. Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions. Ophthalmology. 1989;96:364-366.
19. Saxena S, Kumar D. Visual outcome of branch retinal vein occlusion in Eales' disease. Ann Ophthalmol. 1999;31:173-175.
20. Saxena S, Kumar D. Visual outcome of patients with central Eales disease. Ann Ophthalmol. 2001;33:300-302.
21. Bhooma V, Sulochana KN, Biswas J, Ramakrishnan S. Eales' disease: Accumulation of reactive oxygen intermediates and lipid peroxides and decrease of antioxidants causing inflammation, neovascularization and retinal damage. Curr Eye Res. 1997;16:91-5.
22. Stubbs CD. Membrane fluidity: Structure dynamics of membrane lipids. Essays Biochem. 1983;19:1-39.